Skip to main content
Caplight Logo









Iconeus

Iconeus

Private
ParisHealthcare & Life Scienceshttps://iconeus.com/

Last Round

Grant

Apr 11, 2022

Total Funding Raised

$1.28M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Iconeus is a biotechnology company that develops functional ultrasound (fUS) neuroimaging solutions for preclinical neuroscience research and clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Biotech Equipment, Medical Devices, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

functional ultrasound imagingfUSneuroscience researchneurovascular imagingbrain activity mappingmedical imaging hardwarepreclinical imagingneuroimagingdrug discoverybiotech equipmentneurovascular couplinganimal modelslab techin vivo imagingresearch tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Iconeus Comparables

Compare Iconeus with similar companies based on industry and business-model similarity.

Iconeus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fujifilm Holdings Corporation
77%
S-Sharp Corporation
77%
MR Solutions
76%

Iconeus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 11, 2022
GrantJan 22, 2020

Key People

Founding team and executive leadership

Ludovic Lecointre

CEO & Co-founder

Founding Team

Irma Tanon

Chief Financial Officer

Executive Team

Iconeus Investors

Notable investors and investment history

Iconeus investors
InvestorRounds
AgoranovAccelerator
European Innovation Council FundGrant
Paris Biotech SantéAccelerator
European Commission (Horizon Europe)Grant
PC'up IncubatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 50% MoM, reaching 5.5K.

  • Jun 16, 2026

    Added Physio-Tech Co., Ltd. from Life Sciences / Medical Equipment.

Iconeus Filings

Explore SEC and related filing metadata, where available.

Iconeus filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Iconeus's valuation, stock price, and market status.

Is Iconeus a public or private company?

Iconeus is a private company.

What is the current stock price of Iconeus?

Iconeus is a private company with no public stock price. No recent secondary market data is available.

How much is Iconeus worth (valuation)?

Valuation information for Iconeus is not publicly available.

Can I buy Iconeus stock?

Iconeus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Iconeus's last funding round?

Iconeus's most recent funding round was Grant on April 11, 2022.

Who are the main investors in Iconeus?

Key investors in Iconeus include European Innovation Council, European Commission (Horizon Europe).

Will Iconeus IPO soon?

No public IPO plans have been announced for Iconeus.

How can I track Iconeus secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Iconeus's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range33
Year Founded2016
Last FundingApr 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?